Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China

Core Insights - Visionary Holdings Inc. has established three new wholly owned subsidiaries in Qingdao, Wuxi, and Wuhu, China, marking a significant operational milestone in its commercialization strategy [1][2][10] Group 1: Subsidiary Functions - The new subsidiaries will focus on localized market expansion, institutional partnerships, and frontline sales execution for GV's regenerative medicine and aesthetic treatment products [2][4][5] - Each subsidiary will recruit professional sales teams to support hospitals, aesthetic clinics, and premium wellness institutions [4] - Strategic cooperation will be developed with regional medical providers and healthcare platforms to enhance market presence [5] Group 2: Commercialization Strategy - The establishment of these subsidiaries is part of a phased strategic roadmap that includes the Shandong Peninsula, Yangtze River Delta, and Anhui regional healthcare markets [8] - The company has secured global technology licensing in regenerative medicine and launched a stem cell-based anti-aging product portfolio [9] - The multi-city deployment aims to strengthen scalability and long-term growth foundations for the company [12] Group 3: Operational Enhancements - The expansion enhances commercial scalability, institutional penetration capability, revenue pathway visibility, and regional diversification [16] - The integrated operational platforms now span multiple cities, providing a structured approach to strategy, technology, product, and sales execution [12][13] - As demand for regenerative medicine and aesthetic treatments grows in Asia, the company's structured commercialization approach positions it to capitalize on this trend [13]